Kim, Wooseong
Zhu, Wenpeng
Hendricks, Gabriel Lambert
Van Tyne, Daria
Steele, Andrew D.
Keohane, Colleen E.
Fricke, Nico
Conery, Annie L.
Shen, Steven
Pan, Wen
Lee, Kiho
Rajamuthiah, Rajmohan
Fuchs, Beth Burgwyn
Vlahovska, Petia M.
Wuest, William M.
Gilmore, Michael S.
Gao, Huajian
Ausubel, Frederick M.
Mylonakis, Eleftherios
Article History
Received: 31 August 2016
Accepted: 26 February 2018
First Online: 28 March 2018
Competing interests
: F.M.A. and E.M. have interests in Genma Biosciences, Inc. and Octagon Therapeutics, Inc., companies that are engaged in developing antimicrobial compounds. The interests of E.M. and F.M.A. were reviewed and are managed by Rhode Island Hospital (E.M.) and Massachusetts General Hospital and Partners HealthCare (F.M.A.) in accordance with their conflict of interest policies. The remaining authors declare no competing interests.